BioStem Technologies Announces Notice of Allowance for Four U.S. Design Patent Applications Covering Fenestrated Human Placental Allografts and One European Patent
BioStem Technologies announced that the USPTO issued Notices of Allowance for four U.S. design patents covering its fenestrated human placental allograft technologies. The European Patent Office also granted a new patent for sterile human placental allografts and proprietary manufacturing methods that preserve growth factors.
Key figures
- Total patent portfolio
- more than 70
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.